Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TUMOR”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07565285
What this trial is testing

The Efficacy and Safety of PRTX007-003 Combined With Pembrolizumab in Resectable Stage III Melanoma

Who this might be right for
Melanoma Stage III
Primmune Therapeutics, Inc. 48
Not applicableStudy completedNCT05435885
What this trial is testing

Postoperative Telerehabilitation in Older Adults

Who this might be right for
TelerehabilitationCarcinoma, Non-Small-Cell LungCardiopulmonary Exercise Test
Pusan National University Hospital 64
Early research (Phase 1)Looking for participantsNCT07067385
What this trial is testing

Personalized mRNA Cancer Vaccine for Gastrointestinal Solid Tumor Treatment

Who this might be right for
Personalized Neoantigen Vaccine in Combination With Anti-PD-1 Inhibitors in Standard Therapy-Failed and Adjuvant TherapyGastrointestinal Tumors
Ruijin Hospital 40
Not applicableUnknownNCT02526043
What this trial is testing

Laparoscopic Versus Open Liver Resection for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fudan University 180
Early research (Phase 1)Study completedNCT00074243
What this trial is testing

CC-8490 in Treating Patients With Recurrent or Refractory High-Grade Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT00061815
What this trial is testing

Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer

Who this might be right for
Colorectal Cancer
Eli Lilly and Company 102
Large-scale testing (Phase 3)Study completedNCT02234115
What this trial is testing

Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma

Who this might be right for
Prostatic Neoplasms
Foresee Pharmaceuticals Co., Ltd. 137
Testing effectiveness (Phase 2)Study completedNCT01222936
What this trial is testing

LBH Phase II in Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Carcinoma
Southern Europe New Drug Organization 21
Early research (Phase 1)UnknownNCT02013336
What this trial is testing

Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors

Who this might be right for
Recurrent or Refractory Solid TumorsEwing SarcomaRhabdomyosarcoma+2 more
South Plains Oncology Consortium 30
Testing effectiveness (Phase 2)Study completedNCT00318136
What this trial is testing

Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer (BRIDGE)

Who this might be right for
Non-small Cell Lung Cancer
Genentech, Inc. 47
Not applicableNo Longer AvailableNCT05269771
What this trial is testing

MAP to Provide Access to Ruxolitinib, for Patients With Polycythemia Vera

Who this might be right for
Polycythemia Vera
Novartis Pharmaceuticals
Not applicableUnknownNCT04506671
What this trial is testing

Percutaneous Cryoablation Versus Partial Nephrectomy for T1b Renal Tumor

Who this might be right for
Renal Tumor
I.M. Sechenov First Moscow State Medical University 142
Not applicableStudy completedNCT05524844
What this trial is testing

The Microbiome, Bile Acids, and Notch in Barrett's Esophagus (BE)

Who this might be right for
Barrett EsophagusEsophageal Adenocarcinoma
Columbia University 54
Not applicableActive Not RecruitingNCT07485634
What this trial is testing

Risk-Based Geriatric Assessment-Driven Management in Older Patients Starting Chemotherapy

Who this might be right for
CancerGeriatric SyndromeFrailty+1 more
The University of Hong Kong 70
Testing effectiveness (Phase 2)Looking for participantsNCT06406634
What this trial is testing

Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Hunan Cancer Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01523834
What this trial is testing

Oral Panobinostat Adult Patients DLBCL Relapsed/Refractory Stem Cell Transfusion (ASCT) or Not Eligible for ASCT

Who this might be right for
Diffuse Large B-cell Lymphoma
Fondazione Italiana Linfomi - ETS 35
Not applicableUnknownNCT03982264
What this trial is testing

Endoscopic Treatment of Rectal Neuroendocrine Tumor(NET) Less Than 10mm

Who this might be right for
Rectal Neuroendocrine Tumor
Nanfang Hospital, Southern Medical University 90
Testing effectiveness (Phase 2)WithdrawnNCT04044209
What this trial is testing

The IDH1 Inhibitor AG-120 in Combination With the Checkpoint Blockade Inhibitor, Nivolumab, for Patients With IDH1 Mutated Relapsed/Refractory AML and High Risk MDS

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid Leukemia
Yale University
Not applicableLooking for participantsNCT06983899
What this trial is testing

Exercise Training for the Improvement of Immune Activity and Treatment Outcomes During Immunotherapy for Non-small Cell Lung Cancer, BOOST Trial

Who this might be right for
Lung Non-Small Cell Carcinoma
Fred Hutchinson Cancer Center 100
Testing effectiveness (Phase 2)UnknownNCT04223999
What this trial is testing

Improving Tumor Treating Fields Treatment for Brain Cancer Patients With Skullremodeling Surgery (Neurosurgery)

Who this might be right for
Recurrent Glioblastoma
Anders Rosendal Korshøj 70
Next Page